Position in XNCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,744,199
+$6,390,156 QoQ
Shares Held
853,677
+40.0% QoQ
Ownership
1.15%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 208 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XNCR Over Time
Shares Held
Position Value (USD)
Derivatives in XNCR
reported options exposure · as of Mar 31, 2023CallValue
$560,589
CallShares
20,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,585,112 across 322 Biotechnology names. XNCR ranks #76 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in XNCR
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,744,199 | 853,677 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,354,043 | 609,788 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,100,799 | 594,435 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,241,193 | 702,574 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,726,901 | 346,934 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $631,835 | 59,383 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $28,441,492 | 1,414,296 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $15,539,088 | 820,871 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $18,212,458 | 822,976 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,435,043 | 350,214 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,658,480 | 727,468 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,027,155 | 321,472 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $274,660 | 9,848 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $560,589 | 20,100 | Call | Sole | 2023-05-15 | |
| 2022-12-31 | $1,058,343 | 40,643 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $227,896 | 8,772 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,754,012 | 246,767 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,778,667 | 254,073 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $928,778 | 23,150 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $673,122 | 20,610 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,724,647 | 136,986 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $861,200 | 20,000 | Call | Sole | 2021-05-17 | |
| 2021-03-31 | $1,223,334 | 28,410 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $872,600 | 20,000 | Call | Sole | 2021-02-16 | |
| 2020-12-31 | $566,404 | 12,982 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $424,323 | 10,939 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $1,690,849 | 56,588 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||